Compare BHC & ADBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BHC | ADBT |
|---|---|---|
| Founded | N/A | N/A |
| Country | Canada | Japan |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.4B |
| IPO Year | 1996 | 2025 |
| Metric | BHC | ADBT |
|---|---|---|
| Price | $5.81 | $0.12 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | 2.0M | ★ 36.9M |
| Earning Date | 04-29-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 423.08 | N/A |
| EPS | N/A | ★ 0.01 |
| Revenue | ★ $8,724,000,000.00 | N/A |
| Revenue This Year | $4.61 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $18.43 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.33 | $0.09 |
| 52 Week High | $8.00 | $4.94 |
| Indicator | BHC | ADBT |
|---|---|---|
| Relative Strength Index (RSI) | 39.53 | 1.26 |
| Support Level | $5.42 | N/A |
| Resistance Level | $5.96 | $0.18 |
| Average True Range (ATR) | 0.24 | 0.29 |
| MACD | -0.10 | -0.02 |
| Stochastic Oscillator | 9.76 | 0.78 |
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.